| scholarly article | Q13442814 |
| P50 | author | Charles N Serhan | Q87981947 |
| P2093 | author name string | Nan Chiang | |
| Romain A Colas | |||
| Jesmond Dalli | |||
| P2860 | cites work | Cloning and chromosomal localization of a gene (GPR18) encoding a novel seven transmembrane receptor highly expressed in spleen and testis | Q24313510 |
| The lipid mediator protectin D1 inhibits influenza virus replication and improves severe influenza | Q24324009 | ||
| Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals | Q24673096 | ||
| Anti-inflammatory therapy in chronic disease: challenges and opportunities | Q26860162 | ||
| Resolution phase lipid mediators of inflammation: agonists of resolution | Q27687489 | ||
| Rainbow trout (Oncorhynchus mykiss) brain cells biosynthesize novel docosahexaenoic acid-derived resolvins and protectins-Mediator lipidomic analysis | Q28193495 | ||
| Identification of the orphan G protein-coupled receptor GPR31 as a receptor for 12-(S)-hydroxyeicosatetraenoic acid | Q28241946 | ||
| Identification of N-arachidonylglycine as the endogenous ligand for orphan G-protein-coupled receptor GPR18 | Q28252255 | ||
| Resolvin D1 binds human phagocytes with evidence for proresolving receptors | Q28270638 | ||
| GPR18 is required for a normal CD8αα intestinal intraepithelial lymphocyte compartment. | Q28511668 | ||
| Food-related illness and death in the United States | Q29615940 | ||
| Resolvin D2 restores neutrophil directionality and improves survival after burns | Q30539988 | ||
| Pro-resolving lipid mediators are leads for resolution physiology | Q30829097 | ||
| Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis | Q33513370 | ||
| Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue | Q33840123 | ||
| Leukotriene B4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusion | Q33853630 | ||
| Omega-3 fatty acid-derived mediators 17(R)-hydroxy docosahexaenoic acid, aspirin-triggered resolvin D1 and resolvin D2 prevent experimental colitis in mice. | Q34197156 | ||
| Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators | Q34294883 | ||
| Plasma metabolomics in human pulmonary tuberculosis disease: a pilot study | Q34343488 | ||
| Sepsis: current dogma and new perspectives | Q34415915 | ||
| Effects of D-series resolvins on behavioral and neurochemical changes in a fibromyalgia-like model in mice. | Q34424812 | ||
| Resolvins and protectins in inflammation resolution. | Q35332873 | ||
| Resolution of inflammation by N-arachidonoylglycine | Q35388701 | ||
| Baking reduces prostaglandin, resolvin, and hydroxy-fatty acid content of farm-raised Atlantic salmon (Salmo salar) | Q35567528 | ||
| Resolvin D2 is a potent endogenous inhibitor for transient receptor potential subtype V1/A1, inflammatory pain, and spinal cord synaptic plasticity in mice: distinct roles of resolvin D1, D2, and E1. | Q35623911 | ||
| Resolvin E1 promotes phagocytosis-induced neutrophil apoptosis and accelerates resolution of pulmonary inflammation | Q36236176 | ||
| Efficient clearance of early apoptotic cells by human macrophages requires M2c polarization and MerTK induction | Q36301713 | ||
| Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk | Q36733068 | ||
| Diversity of lipid mediators in human adipose tissue depots. | Q36923555 | ||
| Fresh approaches to anti-infective therapies | Q37015858 | ||
| Resolvin D2 prevents secondary thrombosis and necrosis in a mouse burn wound model | Q37102819 | ||
| Lipid mediators in health and disease: enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation | Q37286185 | ||
| Ischemia and reperfusion--from mechanism to translation | Q37455225 | ||
| Innate immunity to intracellular pathogens: macrophage receptors and responses to microbial entry | Q37846862 | ||
| Evaluating cellular impedance assays for detection of GPCR pleiotropic signaling and functional selectivity | Q39884754 | ||
| Infection regulates pro-resolving mediators that lower antibiotic requirements | Q42095762 | ||
| Influenza--time to target the host? | Q42284811 | ||
| G-protein coupled receptor 18 (GPR18) in channel catfish: expression analysis and efficacy as immunostimulant against Aeromonas hydrophila infection | Q44948012 | ||
| Resolvin D1-mediated NOX2 inactivation rescues macrophages undertaking efferocytosis from oxidative stress-induced apoptosis | Q48004057 | ||
| Mapping of the novel G protein-coupled receptor Gpr18 to distal mouse chromosome 14. | Q48057155 | ||
| Regulation of macrophage phagocytosis of apoptotic cells by cAMP | Q60129335 | ||
| Lipoxin-induced migration of fish leukocytes | Q67506319 | ||
| Lipoxin formation in fish leucocytes | Q67968692 | ||
| Resolvins D1, D2, and other mediators of self-limited resolution of inflammation in human blood following n-3 fatty acid supplementation | Q84847121 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | resolvin D2 | Q60998704 |
| P304 | page(s) | 1203-17 | |
| P577 | publication date | 2015-07-27 | |
| P1433 | published in | Journal of Experimental Medicine | Q3186912 |
| P1476 | title | Identification of resolvin D2 receptor mediating resolution of infections and organ protection | |
| P478 | volume | 212 |
| Q64997779 | A maresin 1/RORα/12-lipoxygenase autoregulatory circuit prevents inflammation and progression of nonalcoholic steatohepatitis. |
| Q57284070 | A review of inflammatory mechanism in airway diseases |
| Q41068189 | ALX receptor ligands define a biochemical endotype for severe asthma |
| Q90236677 | Accelerating the reversal of inflammatory pain with NPD1 and its receptor GPR37 |
| Q92511318 | Activation of Resolution Pathways to Prevent and Fight Chronic Inflammation: Lessons From Asthma and Inflammatory Bowel Disease |
| Q28074701 | Advances in understanding COPD |
| Q43075623 | An Update on Non-CB1, Non-CB2 Cannabinoid Related G-Protein-Coupled Receptors |
| Q100635354 | Anti-inflammatory signaling through G protein-coupled receptors |
| Q46142237 | Astrocyte-derived lipoxins A4 and B4 promote neuroprotection from acute and chronic injury |
| Q88111937 | Biosynthesis of D-Series Resolvins in Skin Provides Insights into their Role in Tissue Repair |
| Q38681468 | Boosting Inflammation Resolution in Atherosclerosis: The Next Frontier for Therapy |
| Q39271007 | Bronchoprotective mechanisms for specialized pro-resolving mediators in the resolution of lung inflammation |
| Q99201955 | Carcinogenesis: Failure of resolution of inflammation? |
| Q39020047 | Combination of aspirin with essential fatty acids is superior to aspirin alone to prevent or ameliorate sepsis or ARDS. |
| Q37624373 | Corticosteroids inhibit anti-IgE activities of specialized proresolving mediators on B cells from asthma patients |
| Q92630310 | Cyclic AMP Regulates Key Features of Macrophages via PKA: Recruitment, Reprogramming and Efferocytosis |
| Q92539077 | Cytokines in Pain: Harnessing Endogenous Anti-Inflammatory Signaling for Improved Pain Management |
| Q36101290 | DHA but Not EPA Emulsions Preserve Neurological and Mitochondrial Function after Brain Hypoxia-Ischemia in Neonatal Mice |
| Q28269550 | DHA- and EPA-derived resolvins, protectins, and maresins in airway inflammation |
| Q92155618 | Dietary Fatty Acids and Microbiota-Brain Communication in Neuropsychiatric Diseases |
| Q39163938 | Discovery of specialized pro-resolving mediators marks the dawn of resolution physiology and pharmacology |
| Q97519129 | Distinct Profiles of Specialized Pro-resolving Lipid Mediators and Corresponding Receptor Gene Expression in Periodontal Inflammation |
| Q37117284 | Dual Roles of Group IID Phospholipase A2 in Inflammation and Cancer |
| Q62661525 | Dynamic changes to lipid mediators support transitions among macrophage subtypes during muscle regeneration |
| Q42373874 | ERV1 Overexpression in Myeloid Cells Protects against High Fat Diet Induced Obesity and Glucose Intolerance |
| Q92537262 | Effect of Ulinastatin Combined With Dexmedetomidine on Postoperative Cognitive Dysfunction in Patients Who Underwent Cardiac Surgery |
| Q91855383 | Efferocytosis in health and disease |
| Q93345082 | Emerging role of 12/15-Lipoxygenase (ALOX15) in human pathologies |
| Q59791745 | Exploiting the Multifaceted Effects of Cannabinoids on Mood to Boost Their Therapeutic Use Against Anxiety and Depression |
| Q96577391 | Free fatty acid receptor 4 (FFA4) activation ameliorates 2,4-dinitrochlorobenzene-induced atopic dermatitis by increasing regulatory T cells in mice |
| Q91921361 | Function of Pro-Resolving Lipid Mediator Resolvin E1 in Type 2 Diabetes |
| Q52579146 | G-Protein Coupled Receptor 18 Contributes to Establishment of the CD8 Effector T Cell Compartment. |
| Q91633418 | GPR101 mediates the pro-resolving actions of RvD5n-3 DPA in arthritis and infections |
| Q38441639 | Human milk proresolving mediators stimulate resolution of acute inflammation |
| Q40473067 | Identification and Actions of the Maresin 1 Metabolome in Infectious Inflammation. |
| Q64898835 | Identification and structure elucidation of the pro-resolving mediators provides novel leads for resolution pharmacology. |
| Q38594922 | In the eye of the neutrophil swarm-navigation signals that bring neutrophils together in inflamed and infected tissues |
| Q40201663 | Inhibition of Phosphodiesterase-4 during Pneumococcal Pneumonia Reduces Inflammation and Lung Injury in Mice |
| Q59328896 | Lipoxin and Resolvin Receptors Transducing the Resolution of Inflammation in Cardiovascular Disease |
| Q37041858 | Macrophage Proresolving Mediators-the When and Where |
| Q99551345 | Macrophages and the maintenance of homeostasis |
| Q29248094 | Maresin 1 induces a novel pro-resolving phenotype in human platelets |
| Q57107268 | Metabolites as regulators of insulin sensitivity and metabolism |
| Q90671281 | Microglia in Pain: Detrimental and Protective Roles in Pathogenesis and Resolution of Pain |
| Q39249384 | Modulation of innate immunity of patients with Alzheimer's disease by omega-3 fatty acids |
| Q38627502 | New pro-resolving n-3 mediators bridge resolution of infectious inflammation to tissue regeneration |
| Q42378804 | Non-steroidal anti-inflammatory drug delays corneal wound healing by reducing production of 12-hydroxyheptadecatrienoic acid, a ligand for leukotriene B4 receptor 2. |
| Q28274634 | Novel Endogenous Proresolving Molecules:Essential Fatty Acid-Derived and Gaseous Mediators in the Resolution of Inflammation |
| Q40403661 | Novel Resolvin D2 Receptor Axis in Infectious Inflammation. |
| Q89994969 | Omega-3 Fatty Acid-Derived Resolvin D2 Regulates Human Placental Vascular Smooth Muscle and Extravillous Trophoblast Activities |
| Q64262088 | Omega-3 fatty acids suppress Fusobacterium nucleatum-induced placental inflammation originating from maternal endothelial cells |
| Q52369219 | Paradigm shift - Metabolic transformation of docosahexaenoic and eicosapentaenoic acids to bioactives exemplify the promise of fatty acid drug discovery. |
| Q41222249 | Peripheral Interaction of Resolvin D1 and E1 with Opioid Receptor Antagonists for Antinociception in Inflammatory Pain in Rats |
| Q48643086 | Prevention of Chronic Post-Thoracotomy Pain in Rats By Intrathecal Resolvin D1 and D2: Effectiveness of Perioperative and Delayed Drug Delivery |
| Q36217771 | Pro-Resolving Effects of Resolvin D2 in LTD4 and TNF-α Pre-Treated Human Bronchi |
| Q92879646 | Pro-Resolving Lipid Mediators in the Pathophysiology of Asthma |
| Q37728979 | Pro-Resolving Molecules-New Approaches to Treat Sepsis? |
| Q51736941 | Pro-resolving mediators promote resolution in a human skin model of UV-killed Escherichia coli-driven acute inflammation. |
| Q92678361 | Proresolving Lipid Mediators and Receptors in Stem Cell Biology: Concise Review |
| Q27334082 | Proresolving and cartilage-protective actions of resolvin D1 in inflammatory arthritis |
| Q89996972 | Proresolving mediator profiles in cerebrospinal fluid are linked with disease severity and outcome in adults with tuberculous meningitis |
| Q92920992 | Regulation of Apoptotic Cell Clearance During Resolution of Inflammation |
| Q38899898 | Regulation of inflammation by lipid mediators in oral diseases |
| Q37603197 | Resolution of Acute Inflammation and the Role of Resolvins in Immunity, Thrombosis, and Vascular Biology |
| Q33882297 | Resolution of Cochlear Inflammation: Novel Target for Preventing or Ameliorating Drug-, Noise- and Age-related Hearing Loss |
| Q92061664 | Resolution of Inflammation in Neurodegenerative Diseases: The Role of Resolvins |
| Q38791244 | Resolution of inflammation: a new therapeutic frontier |
| Q40990678 | Resolvin D1 and D2 Reverse Lipopolysaccharide-Induced Depression-Like Behaviors Through the mTORC1 Signaling Pathway. |
| Q40245763 | Resolvin D1 enhances the resolution of lung inflammation caused by long-term Pseudomonas aeruginosa infection. |
| Q29248096 | Resolvin D1, resolvin D2 and maresin 1 activate the GSK3β anti-inflammatory axis in TLR4-engaged human monocytes |
| Q34536887 | Resolvin D2 Enhances Postischemic Revascularization While Resolving Inflammation |
| Q64100490 | Resolvin D2 Induces Resolution of Periapical Inflammation and Promotes Healing of Periapical Lesions in Rat Periapical Periodontitis |
| Q55250059 | Resolvin D2 Restrains Th1 Immunity and Prevents Alveolar Bone Loss in Murine Periodontitis. |
| Q40956866 | Resolvin D2 decreases TLR4 expression to mediate resolution in human monocytes |
| Q90235040 | Resolvin D2 elevates cAMP to increase intracellular [Ca2+] and stimulate secretion from conjunctival goblet cells |
| Q49587365 | Resolvin D2 protects against cerebral ischemia/reperfusion injury in rats. |
| Q92105357 | Resolvin D5 Inhibits Neuropathic and Inflammatory Pain in Male But Not Female Mice: Distinct Actions of D-Series Resolvins in Chemotherapy-Induced Peripheral Neuropathy |
| Q48202351 | Resolvin E1, resolvin D1 and resolvin D2 inhibit constriction of rat thoracic aorta and human pulmonary artery induced by the thromboxane mimetic U46619. |
| Q37584891 | Resolvin RvD2 reduces hypothalamic inflammation and rescues mice from diet-induced obesity |
| Q39046533 | Resolving inflammation by using nutrition therapy: roles for specialized proresolving mediators |
| Q88660941 | Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators |
| Q41874893 | Resolvins on the way to resolution |
| Q47225724 | Resolvins suppress tumor growth and enhance cancer therapy. |
| Q95840704 | Role of Resolvins in the Inflammatory Resolution of Neurological Diseases |
| Q99414286 | Roles of Specialized Pro-Resolving Lipid Mediators in Autophagy and Inflammation |
| Q64902212 | Roles of Specialized Pro-Resolving Lipid Mediators in Cerebral Ischemia Reperfusion Injury. |
| Q64084919 | Roles, Actions, and Therapeutic Potential of Specialized Pro-resolving Lipid Mediators for the Treatment of Inflammation in Cystic Fibrosis |
| Q60916595 | Some Prospective Alternatives for Treating Pain: The Endocannabinoid System and Its Putative Receptors GPR18 and GPR55 |
| Q39148416 | Special pro-resolving mediator (SPM) actions in regulating gastro-intestinal inflammation and gut mucosal immune responses |
| Q40140858 | Specialized Pro-resolving Mediators (SPM) Rescue Infant Mice from Lethal Citrobacter rodentium Infection and Promote Immunity against Re-infection |
| Q88540273 | Specialized Proresolving Mediators in Innate and Adaptive Immune Responses in Airway Diseases |
| Q39160278 | Specialized pro-resolving mediators in cardiovascular diseases |
| Q28271331 | Specialized pro-resolving mediators: endogenous regulators of infection and inflammation |
| Q39197238 | Structural elucidation and physiologic functions of specialized pro-resolving mediators and their receptors |
| Q49609716 | Structural insights into Resolvin D4 actions and further metabolites via a new total organic synthesis and validation |
| Q64923754 | The Resolution of Intestinal Inflammation: The Peace-Keeper's Perspective. |
| Q97420826 | The Role of Endogenous Eicosapentaenoic Acid and Docosahexaenoic Acid-Derived Resolvins in Systemic Sclerosis |
| Q91924492 | Towards A Molecular Understanding of The Cannabinoid Related Orphan Receptor GPR18: A Focus on Its Constitutive Activity |
| Q39088075 | Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms |
Search more.